title: Altered Organization of GABA(A) Receptor mRNA Expression in the Depressed Suicide Brain.
abstract: Inter-relationships ordinarily exist between mRNA expression of GABA(A) subunits in the frontopolar cortex (FPC) of individuals that had died suddenly from causes other than suicide. However, these correlations were largely absent in persons that had died by suicide. In the present investigation, these findings were extended by examining GABA(A) receptor expression patterns (of controls and depressed individuals that died by suicide) in the orbital frontal cortex (OFC), hippocampus, amygdala. locus coeruleus (LC) and paraventricular nucleus (PVN), all of which have been implicated in either depression, anxiety or stress responsivity. Using QPCR analysis, we found that in controls the inter-relations between GABA(A) subunits varied across brain regions, being high in the hippocampus and amygdala, intermediate in the LC, and low in the OFC and PVN. The GABA(A) subunit inter-relations were markedly different in persons that died by suicide, being reduced in hippocampus and amygdala, stable in the LC, but more coordinated in the OFC and to some extent in the PVN. It seems that altered brain region-specific inhibitory signaling, stemming from altered GABA(A) subunit coordination, are associated with depression/suicide. Although, it is unknown whether GABA(A) subunit re-organization was specifically tied to depression, suicide, or the accompanying distress, these data show that the coordinated expression of this transcriptome does vary depending on brain region and is plastic.
authors.affiliation: Molecular Brain Research Group, Department of Physiology and Pharmacology, Robarts Research Institute, University of Western Ontario London, Ontario, Canada.
authors.forename: Michael O
authors.initials: MO
authors.lastname: Poulter
authors.forename: Lisheng
authors.initials: L
authors.lastname: Du
authors.forename: Vladimir
authors.initials: V
authors.lastname: Zhurov
authors.forename: Miklós
authors.initials: M
authors.lastname: Palkovits
authors.forename: Gábor
authors.initials: G
authors.lastname: Faludi
authors.forename: Zul
authors.initials: Z
authors.lastname: Merali
authors.forename: Hymie
authors.initials: H
authors.lastname: Anisman
references.citation: Pharmacol Rev. 1999 Sep;51(3):533-91
references.pmid: 10471417
references.citation: J Neurosci. 2004 Feb 11;24(6):1478-85
references.pmid: 14960621
references.citation: Pharmacol Ther. 2003 Jun;98(3):299-323
references.pmid: 12782242
references.citation: Biol Psychiatry. 2000 Oct 15;48(8):813-29
references.pmid: 11063977
references.citation: Arch Gen Psychiatry. 2003 Aug;60(8):804-15
references.pmid: 12912764
references.citation: Eur J Neurosci. 2004 Oct;20(8):2141-8
references.pmid: 15450093
references.citation: J Physiol. 1999 Jan 1;514 ( Pt 1):27-45
references.pmid: 9831714
references.citation: Curr Opin Pharmacol. 2002 Feb;2(1):23-33
references.pmid: 11786305
references.citation: J Neurosci. 2006 Oct 11;26(41):10387-96
references.pmid: 17035523
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15653-8
references.pmid: 16230605
references.citation: Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):172-80
references.pmid: 10581410
references.citation: J Biol Chem. 2004 Sep 24;279(39):40451-61
references.pmid: 15265862
references.citation: Mol Psychiatry. 1996 Sep;1(4):336-42
references.pmid: 9118360
references.citation: OMICS. 2006 Winter;10(4):444-54
references.pmid: 17233556
references.citation: Mol Psychiatry. 2007 Jul;12(7):640-55
references.pmid: 17353912
references.citation: J Neurochem. 2002 Sep;82(6):1512-23
references.pmid: 12354299
references.citation: Nat Neurosci. 2004 Dec;7(12):1345-52
references.pmid: 15558066
references.citation: World J Biol Psychiatry. 2006;7(4):231-7
references.pmid: 17071543
references.citation: Crisis. 2001;22(2):66-70
references.pmid: 11727896
references.citation: Genomics. 1997 Jun 15;42(3):378-87
references.pmid: 9205108
references.citation: J Biol Chem. 2006 Oct 6;281(40):29431-5
references.pmid: 16901909
references.citation: Neuropsychologia. 2006;44(3):374-83
references.pmid: 16112148
references.citation: Pharmacol Ther. 2006 Jul;111(1):272-86
references.pmid: 16574235
references.citation: J Neurosci. 1996 Oct 15;16(20):6402-13
references.pmid: 8815919
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12578-83
references.pmid: 16113080
references.citation: Lab Invest. 2001 Jun;81(6):913-6
references.pmid: 11406652
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8600-5
references.pmid: 10900018
references.citation: Hum Mol Genet. 2006 Aug 15;15(16):2533-41
references.pmid: 16835263
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1116-27
references.pmid: 16631126
references.citation: Science. 2003 Jul 18;301(5631):386-9
references.pmid: 12869766
references.citation: Biotechnol Lett. 2006 Oct;28(19):1601-13
references.pmid: 16900335
references.citation: Eur J Neurosci. 2004 May;19(9):2475-87
references.pmid: 15128401
references.citation: J Neurosci. 2000 Mar 1;20(5):1735-45
references.pmid: 10684875
references.citation: Brain Res Mol Brain Res. 1997 Nov;51(1-2):212-9
references.pmid: 9427523
references.citation: J Neurochem. 2000 May;74(5):1858-69
references.pmid: 10800928
references.citation: Biol Psychiatry. 2008 Oct 15;64(8):645-52
references.pmid: 18639864
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3107-12
references.pmid: 12626741
references.citation: J Neurochem. 1994 Apr;62(4):1643-6
references.pmid: 8133292
references.citation: Neurochem Res. 2003 Jun;28(6):965-76
references.pmid: 12718451
references.citation: J Physiol. 1996 Jun 1;493 ( Pt 2):471-84
references.pmid: 8782110
references.citation: Behav Brain Res. 2007 Aug 6;181(2):180-90
references.pmid: 17517441
references.citation: Nat Med. 1998 Oct;4(10):1166-72
references.pmid: 9771750
references.citation: CNS Neurol Disord Drug Targets. 2007 Apr;6(2):127-40
references.pmid: 17430150
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8448-53
references.pmid: 12034876
references.citation: Eur Neuropsychopharmacol. 2006 Apr;16(3):220-3
references.pmid: 16269239
references.citation: Mol Aspects Med. 2006 Apr-Jun;27(2-3):126-39
references.pmid: 16469371
references.citation: Curr Opin Pharmacol. 2007 Feb;7(1):22-6
references.pmid: 17055337
references.citation: J Neurosci. 1999 Oct 1;19(19):8312-8
references.pmid: 10493732
references.citation: J Neurosci. 1997 Nov 1;17(21):8427-42
references.pmid: 9334415
references.citation: Pharmacol Ther. 2006 May;110(2):135-370
references.pmid: 16522330
references.citation: Pharmacol Ther. 2004 Mar;101(3):259-81
references.pmid: 15031002
references.citation: J Neurosci. 1998 Nov 15;18(22):9256-68
references.pmid: 9801365
references.citation: Arch Gen Psychiatry. 2005 May;62(5):529-35
references.pmid: 15867106